Regulatory Science 606:
Regulation of Emerging Technologies and Biological Products (3.0 units)
Policies, testing and regulatory requirements affecting commercialization of biologics and novel medical technologies. Focus on biologics, blood and tissue products, radiopharmaceuticals and nanotechnology
| Section | Session | Type | Time | Days | Registered | Instructor | Location | Syllabus | Info |
|---|---|---|---|---|---|---|---|---|---|
| 49141D | 626 | Lecture | TBA | TBA | 17 of 50 | Frances Richmond, Eunjoo Pacifici,Michael Jamieson | OFFICE |  |